A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis (clinicaltrials.gov) - Apr 12, 2023 - P1 | N=10 | Terminated | Sponsor: Sichuan Clover Biopharmaceuticals, Inc. | N=20 ➔ 10 | Recruiting ➔ Terminated | Trial primary completion date: Feb 2022 ➔ May 2022; terminated
Enrollment change • Trial primary completion date • Trial termination • Oncology • Peritoneal Cancer
|